Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001662252-16-000271
Filing Date
2016-11-30
Accepted
2016-11-30 14:32:23
Documents
1
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form3.html 3  
1 OWNERSHIP DOCUMENT form3.xml 3 2123
  Complete submission text file 0001662252-16-000271.txt   3661
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Benz Edward J. JR (Reporting) CIK: 0001691160 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37937 | Film No.: 162024988